AEMD Shares Outstanding History
Below is a table of the AEMD shares outstanding history going back to 4/14/2015:

Date AEMD Shares Outstanding

Also see: AEMD Market Cap History
AEMD Historical Shares Outstanding:
+76.82% CAGR
AEMD Historical Shares Outstanding: +76.82% CAGR

Mouse over chart for data details
4/14/2015 ...2/4/2021
Aethlon Medical is a medical technology company. The Aethlon Hemopurifier® is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The U.S. Food and Drug Administration has designated the Hemopurifier as a Breakthrough Device for two independent indications: the treatment of individuals with metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease; and the treatment of life-threatening viruses that are not addressed with approved therapies. We show 27 historical shares outstanding datapoints in our coverage of AEMD's shares outstanding history.

Understanding the changing numbers of AEMD shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like AEMD versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching AEMD by allowing them to research AEMD shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for AEMD:
AEMD SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aethlon Medical (AEMD) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

AERI Shares Outstanding History
AEZS Shares Outstanding History
AGEN Shares Outstanding History
AGIO Shares Outstanding History
AGLE Shares Outstanding History
AGN Shares Outstanding History
AGRX Shares Outstanding History
AGTC Shares Outstanding History
AHPI Shares Outstanding History
AIMT Shares Outstanding History
More Healthcare companies »


AEMD Shares Outstanding History | | Copyright © 2017 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.